Clinical Trial

A Phase 2 Study of HW211026

Name: A Phase 2 Study of HW211026 — clinical trial record (NCT07513454)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, open-label, parallel-group, Phase II clinical trial designed to evaluate the efficacy and safety of HW211026 in adult patients with actinic keratosis.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-31.

Trial Details

NCT Number	NCT07513454
Lead Sponsor	Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Conditions	Actinic Keratosis
Enrollment	80 participants
Start Date	2026-07
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-09